The Study of ICP-248 in Patients With Mature B-cell Malignancies

Clinical trial NCT05728658 · RECRUITING

Trial details

NCT number: NCT05728658
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hematological Malignancies

Start date: 2023-03-09
Primary completion: 2025-08-30
Enrollment: 191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.